Colombo City Holdings PLC

COSE:PHAR.N0000 Stock Report

Market Cap: LK₨1.3b

Colombo City Holdings Past Earnings Performance

Past criteria checks 3/6

Colombo City Holdings has been growing earnings at an average annual rate of 20.8%, while the Real Estate industry saw earnings growing at 9.6% annually. Revenues have been declining at an average rate of 11% per year. Colombo City Holdings's return on equity is 12.3%, and it has net margins of 502.9%.

Key information

20.8%

Earnings growth rate

20.8%

EPS growth rate

Real Estate Industry Growth3.9%
Revenue growth rate-11.0%
Return on equity12.3%
Net Margin502.9%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Colombo City Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

COSE:PHAR.N0000 Revenue, expenses and earnings (LKR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2461307360
30 Jun 2468427340
31 Mar 2477419340
31 Dec 2387254350
30 Sep 2395222340
30 Jun 2397137340
31 Mar 238886340
31 Dec 22-502-6410
30 Sep 22-51833410
30 Jun 224329400
31 Mar 223833380
31 Dec 21615-278320
30 Sep 21619-306300
30 Jun 2150-319360
31 Mar 2156-306350
31 Dec 2060160320
30 Sep 2063166330
30 Jun 2063188250
31 Mar 2061185270
31 Dec 1955245270
30 Sep 1941248260
30 Jun 1928241250
31 Mar 1917245220
31 Dec 18108112160
30 Sep 18110324170
30 Jun 18113293210
31 Mar 18115262210
31 Dec 1718203590
30 Sep 1722200580
30 Jun 1725205540
31 Mar 1728213520
31 Dec 1627571180
30 Sep 1631338200
30 Jun 1635345180
31 Mar 1640348180
31 Dec 154883200
30 Sep 154889160
30 Jun 1550121180
31 Mar 1551113220
31 Dec 1452111150
30 Sep 1451103200
30 Jun 144962270
31 Mar 144664240
31 Dec 13-953110

Quality Earnings: PHAR.N0000 has a high level of non-cash earnings.

Growing Profit Margin: PHAR.N0000's current net profit margins are higher than last year .


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: PHAR.N0000's earnings have grown significantly by 20.8% per year over the past 5 years.

Accelerating Growth: PHAR.N0000's earnings growth over the past year (38.6%) exceeds its 5-year average (20.8% per year).

Earnings vs Industry: PHAR.N0000 earnings growth over the past year (38.6%) did not outperform the Real Estate industry 47.9%.


Return on Equity

High ROE: PHAR.N0000's Return on Equity (12.3%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies